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Abstract
Mutations in mitochondrial tRNA genes have been shown to be associated with maternally inherited syn-
dromic and non-syndromic deafness. Among those, mutations such as tRNALeu(UUR) 3243A>G associated with
syndromic deafness are often present in heteroplasmy, and the non-syndromic deafness-associated tRNA mu-
tations including tRNASer(UCN) 7445A>G are often in homoplasmy or in high levels of heteroplasmy. These
tRNA mutations are the primary factors underlying the development of hearing loss. However, other tRNA
mutations such as tRNAThr 15927G>A and tRNASer(UCN) 7444G>A are insufficient to produce a deafness phe-
notype, but always act in synergy with the primary mitochondrial DNA mutations, and can modulate their
phenotypic manifestation. These tRNA mutations may alter the structure and function of the corresponding
mitochondrial tRNAs and cause failures in tRNAs metabolism. Thereby, the impairment of mitochondrial
protein synthesis and subsequent defects in respiration caused by these tRNA mutations, results in mitochon-
drial dysfunctions and eventually leads to the development of hearing loss. Here, we summarized the deaf-
ness-associated mitochondrial tRNA mutations and discussed the pathophysiology of these mitochondrial
tRNA mutations, and we hope these data will provide a foundation for the early diagnosis, management, and
treatment of maternally inherited deafness.
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Introduction
Deafness is a very common congenital disorder affect-
ing 1 in every 700-1000 newborns, which can be caused
by hereditary and environmental factors including ototox-
ic drugs such as aminoglycosides[1,2]. Deafness can be
classified into syndromic deafness (hearing loss com-
bined with other medical conditions such as diabetes),
and non-syndromic deafness (hearing loss as the only ob-
vious medical problem). Mutations in mitochondrial
DNA (mtDNA) have been found to be one of the most
important causes of maternally inherited syndromic and
non-syndromic deafness[3-7]. Among those mutations, the
12S rRNA 1555A>G and 1494C>T mutations have been
proved to be associated with aminoglycoside ototoxicity
and non-syndromic deafness in many families from dif-
ferent ethnic backgrounds[3-5].On the other hand, mito-
chondrial tRNA genes are also known as hot spots for
mutations associated with both syndromic and non-syn-
dromic hearing loss[6, 7]. In this review, we summarized
deafness-associated mitochondrial tRNA mutations and
discussed the molecular pathogenetic mechanism of deaf-
ness associated tRNA mutations.
Mitochondrial tRNA
In human cells, 22 tRNAs required for the mitochondri-
al protein synthesis are encoded by mtDNA, which is a
double-strand circular molecule with 16,569 base pairs[8, 9].
Among these, 8 tRNAs including tRNAGlu, tRNAA1a,
tRNAAsn, tRNACys, tRNATyr, tRNASer(UCN), tRNAGln and
tRNAPro reside at the cytosine-rich light (L) strand, the re-
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maining tRNAPhe, tRNAVal, tRNALeu(UUR), tRNALeu(CUN),
tRNAIle, tRNAMet, tRNASer(AGY), tRNATrp, tRNAAsp, tRNALys,
tRNAGly, tRNAArg, tRNAHis and tRNAThr are located at the
guanine-rich heavy (H) strand[8]. tRNAs often form a
highly conserved cloverleaf structure (Figure 1). Unlike
canonical tRNAs such as human cytosolic tRNAs, hu-
man mitochondrial tRNAs have specific features such as
non-classical G-U pairs and mismatches[10, 11]. As illustrat-
ed in Figure 1, there are three types of unusual second-
ary structures in the mitochondrial tRNAs[10, 12]. The
tRNASer(UCN) has a non-canonical cloverleaf structure with
only one base (A9) between the acceptor stem and D
stem, a short D loop and an extra loop, and an extended
anticodon stem with 6 bp. The tRNASer(AGY) lacks the en-
tire D loop. The other 20 tRNAs with the variable sizes
and sequence of the D-loops and T-loops, but loss the ca-
nonical D-loop/T-loop interaction. Furthermore, mito-
chondrial tRNAs undergo several important post-tran-
scriptional modifications to ensure they are correctly fold-
ed and fully functional[12, 13]. However, comparing with the
cytoplasmic tRNAs, there are less numbers of modified
nucleotides in mitochondrial tRNAs[12].
Primary Deafness-associated tRNA Muta-
tions
In the mitochondrial tRNA genes have been reported
to be responsible for maternally inherited syndromic deaf-
ness and non-syndromic deafness[14]. These tRNA muta-
tions, such as 3243A>G and tRNASer(UCN) 7445A>G, which
referred to as the primary mutations, are the primary fac-
tors for the development of deafness[15, 16]. The syndromic
deafness-associated tRNA mutations such as tRNALeu(UUR)
3243A>G are often present in heteroplasmic form, while
non-syndromic deafness-associated tRNA mutations in-
cluding tRNASer(UCN) 7445A>G are often in homoplasmy
and in high levels of heteroplasmy[3,7].
Primary tRNA mutations associated with syndromic
deafness
The heteroplasmic 3243A>G mutation in tRNALeu(UUR)
gene causes mitochondrial encephalomyopathy, lactic ac-
idosis, and stroke-like symptoms (MELAS)[17]. which is al-
so one of the important causes of maternally inherited di-
abetes and deafness[15, 18]. The primary defect of this muta-
tion is an inefficient aminoacylation of the tRNALeu(UUR)[19, 20]
This mutation also affects the processing of the longer
RNA precursors[21, 22] and the base post-transcriptional
modification of the tRNALeu(UUR) [23]. In cybrids harboring
nearly homoplasmic 3243A>G mutation, the level of ami-
noacylated tRNALeu(UUR) was reduced approximately 70%
to 75%.20, 22 The deficient aminoacylation of tRNALeu(UUR)
mainly contributes to a shortage of tRNALeu(UUR),[20, 22] and
thereby causing a reduced rate of mitochondrial protein
synthesis and respiration defects. Additionally, tRNALeu(UUR)
3291T>C mutation in this tRNA gene, which cause a de-
creased mitochondrial translation by wobble modifica-
tion deficiency, has also been associated with syndromic
deafness[24, 25].
Mutations in the tRNALys gene, including 8344A>G,
8356T>C, and 8363G>A, are always responsible for
myoclonic epilepsy with ragged red fibers (MERRF),
compatible with hearing loss[26-31]. Particularly, decrease
of the steady-state levels and aminoacylation in the
tRNALys were observed in cybrid cell lines carrying the
8344A>G mutation[32]. Furthermore, the lack of wobble
modification caused by 8344A>G mutation disturbed the
condon-anticodon pairing in mutant tRNALys[23]. Alteration
in this tRNA metabolism is apparently responsible for
the defect of mitochondrial translation and respiration[23,32].
The tRNASer(UCN) 7472insC mutation has been report-
ed in several pedigrees with hearing loss, either in isola-
Figure 1 Schematic secondary structure of human mitochondrial tRNAs. Canonical tRNA and three types of mitochondrial tRNAs are
shown. Circled numbers represent the nucleotide positions according to the conventional tRNA numbering system.54 Tertiary interactions
between nucleobases are indicated by dotted lines.
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tion or in combination with ataxia, dysarthria, and, more
rarely, focal myoclonus[33, 34]. Cybrid cells harboring ho-
moplasmic 7472insC mutation exhibited a marked de-
crease (~70%) of tRNASer(UCN) abundance by affecting its
synthesis rather than the structure stability and also a
mild decline (~25% ) in steady-state aminoacylation of
tRNASer(UCN)[35].
In two unrelated pedigrees with syndromic hearing
loss, thepatientswere found toharbor the tRNAGlu 14709T>
C mutation in heteroplasmy. Only a subtle decrease was
found in the steady-state levels of tRNAGlu transcripts by
functional analysis in the cybrids with the mutation[36, 37]
Therefore, the pathogenecity of tRNAGlu 14709T>C mu-
tation need to be further studied by functional evalua-
tions. Moreover, increasing number of putative syndrom-
ic deafness-associated mutations in tRNA genes have
been identified in different families during the past sever-
al years; however, functional analyses are needed to de-
termine the association between these tRNA mutations
and hearing loss[14]
Primary tRNA mutations associated with non-syn-
dromic deafness
The tRNASer(UCN)gene is one of the hot spots for mutations
associated with non-syndromic deafness.7 These muta-
tions include the 7445A>G, 7511T>C and 7505T>C mu-
tations[16, 38, 39]. The primary defect of tRNASer(UCN) mutations
appeared to cause a failure in tRNA metabolism, thereby
altering mitochondrial translation and respiration[40, 41]. In
addition, these mutations often occur in homoplasmy or
in high levels of heteroplasmy, indicating a high thresh-
old for pathogenicity[39-41].
The 7445A>G mutation in the precursor of tRNASer(UCN)
gene has been reported to be associated with deafness in
several genetically pedigrees from Scotland, New Zea-
land, France, Ukraine, Hungary and Japan with or with-
out palmoplantar keratoderma[16, 42-44]. The mutation
changed a frameshift signal (AGA) into AGG of the cyto-
chrome oxidase subunit I (COI) on the heavy (H) strand[45].
Meanwhile, it changes L-strand encoded tRNASer(UCN) pre-
cursorsequenceG↓UCU(↓ indicates the invitro3’-tRNase
processing site) to G↓CCU, which resembles a 3’-tRNase
anti-determinant leading to the 3’end endonucleolytic
processing defect[40,46].In fact, markedly reduced
steady-state levels of tRNASer(UCN) and ND6 mRNA be-
longing to the same precursor of L-strand transcript were
observed in cells carrying the 7445A>G mutation[40, 47].
The altered processing of RNA procurers impairs the
synthesis rate of ND6 subunit and plays a determinant
role in the deafness-associated respiratory phenotype of
the mutant cell lines[40, 47].
The 7511T>C mutation has been found in several fam-
ilies with non-syndromic hearing loss from different eth-
nic groups, including African, French and Japanese[38,48,49].
The 7511T>C mutation converted a highly conserved
A-U to a G-U base pairing on the 5’side of the acceptor
stem of the tRNASer(UCN) [10,41]. Cybrids derived from an af-
fected matrilineal relative carrying the 7511T>C muta-
tion exhibited a ~75% decrease in the steady state level
of tRNASer(UCN), compared with the control cybrids.41
Thus, the amount of tRNASer(UCN) in mutant cells is below
the proposed threshold to support a normal rate of mito-
chondrial protein synthesis. This defect is likely a prima-
ry contributor to ~52% reduction in the rate of mitochon-
drial protein synthesis and mitochondrial dysfunction[41].
The 7505T>C mutation, located at a highly conserved
base-pairing (10A-20U) of tRNASer(UCN), was identified in
a Han Chinese pedigree with maternally transmitted
non-syndromic deafness[39]. The abolishment of 10A-20U
base-pairing very likely alters the tRNASer(UCN) metabo-
lism. Functional significance of this mutation was sup-
ported by ~65% reduction in the level of tRNASer(UCN) ob-
served in the lymphoblastoid cell lines carrying 7505T>C
mutation[39].
Most recently, a heteroplasmic 12201T>C mutation in
tRNAHis has been identified in a large five-generation
Han Chinese pedigree with maternally transmitted late-on-
set non-syndromic hearing loss[50]. Strikingly, the levels
of heteroplasmic 12201T>C mutation in cells correlated
with the severity of hearing loss. The 12201T>C muta-
tion destabilizes a highly conservative base-pairing
(5A-68U) on the acceptor stem of tRNAHis and may al-
ter the secondary structure, thereby causing a defect in
the tRNA metabolism. Functional characterization re-
vealed a ~75% reduction in the steady-state level of
tRNAHis in 12201T>C mutant cell lines, compared with
the wild-type cell lines. The altered tRNA metabolism re-
sults in the impairment of mitochondrial translation and
respiration, which leads to the development of deaf-
ness.50 Furthermore, other putative mutations, including
tRNAPhe 636A>G, tRNATrp 5568A>G, tRNALys 8348A>G
and tRNASer(AGY) 12236G>A, have been found to be asso-
ciated with non-syndromic hearing loss. However, fur-
ther studies are needed for better understanding of their
pathogenecity[14].
Secondary deafness-associated tRNA mu-
tations
Variable phenotypes of hearing loss within and among
families carrying the same primary mtDNA mutation,
such as 1555A>G and 7445A>G mutations, indicated
the involvement of modifiers including the secondary
mtDNA mutations[44,51]. The secondary mutations are in-
sufficient to produce the deafness phenotype by them-
selves, but possess a potential modifier role in the pheno-
typic manifestation of the primary mtDNA mutation. For
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instance, the tRNAThr 15927G>A mutation acts in syner-
gy with the primary 1555A>G mutation, thereby increas-
ing the penetrance and expressivity of hearing loss[52]. On
the contrary, there are some tRNA mutations such as tR-
NALeu(CUN) 12300G>A mutation, appeared to be suppres-
sor of the primary mutation.
Enhancement of phenotypic expression of the pri-
mary mtDNA mutations
The secondary tRNA mutations, such as tRNAThr
15927G>A, tRNASer(UCN)/CO1 7444G>A, tRNACys 5802T>
C, tRNAArg 10454T>C, tRNASer(AGY) 12224C>T, tRNACys
5821G>A, tRNAGlu 14693A>G, and tRNAThr 15908T>C
were implicated to enhance the penetrance and expres-
sivity of hearing loss among Chinese families carrying
the 12S rRNA 1555A>G mutation[51,53]. These variants
are present in homoplasmy, localized at highly con-
served nucleotides of tRNAs and may cause potential
structural and functional alterations. In particular, the
15927G>A variant locates at the fourth base in the anti-
codon stem (conventional position 42) of the tRNAThr.
A guanine (G42) at this position of tRNAThr is highly con-
served from bacteria to human mitochondria[10,54]. The
abolished base-pairing (28C-42G) of this tRNAThr by the
15927G>A mutation likely altered this tRNA metabo-
lism. Functional significance of this variant was support-
ed by the fact that the lower levels and altered electro-
phoretic mobility of tRNAThr were observed in cells carry-
ing 1555A>G and 15927G>A mutations or only 15927G>
A variant, but not in these cells carrying only 1555A>G
mutation.52 Therefore, these deafness-associated second-
ary mutations may aggravate mitochondrial dysfunctions
caused by the 1555A>G mutation, thereby increasing the
penetrance and expressivity of hearing loss in these Chi-
nese pedigrees.
The tRNASer(UCN) 7511T>Cmutation, inconjunction with
the ND1 3308T>C and tRNAAla 5655T>C mutations, con-
tributed to a higher penetrance of hearing loss in a large
African family than these in Japanese and French fami-
lies[38,41,48,49]. In fact, tRNAAla 5655T>C mutations caused a
significant decrease in the amount of tRNAAla, while the
ND1 3308T>C reduced the levels of ND1 mRNA and
co-transcribed tRNALeu(UUR) in mutant cells, respectively[41].
As a consequence, these two mutations aggravated the
mitochondrial dysfunction associated with the 7511T>C
mutation, thereby accounting for the higher penetrance
of deafness in an African family compared with these
Japanese and French families carrying the same primary
mutation[41,48,49]. Furthermore, the tRNAAla 5587T>C may
also play a role in the penetrance and expressivity of the
7505T>C mutation[39].
Suppression of phenotypic expression of the prima-
ry mtDNA mutations
The 12300G>A mutation in the anticodon sequence of
the tRNALeu(CUN) was found in a lung carcinoma cybrid
cell line bearing 99% tRNALeu(UUR) 3243A>G mutant mtD-
NA[19]. In fact, the wild-type tRNALeu(UUR) could efficiently
decode both the UUA and UUG codons, while the 3243A>
G mutant tRNALeu(UUR) exhibited the absence of taurine
modification, resulting in a severe reduction in UUG de-
coding, which was considered to be the important molec-
ular basis of MELAS syndrome[55]. However, mass spec-
trometry analysis showed that the suppressor 12300G>A
mutation acquired a de novo wobble uridine modifica-
tion of UAA anticodon, which could potentially decode
UUR codons, thereby, rescuing the severe impairment of
both mitochondrial translation and respiratory captivity
caused by the 3243A>G mutation[56].
The 7472A>C mutation at the tRNASer(UCN) gene ap-
peared to be suppressor of the primary 7472insC mutation
at the same gene in an Italian family with deafness[57].
Despite harboring the same percentage of 7472insC mu-
tation, the proband developed rapidly progressive en-
cephalopathy with deafness from a low level of hetero-
plasmic 7472A>C mutation, while his mother had only
mild hearing impairment in associated with higher per-
centage of 7472A>C[57]. Subsequently, Swalwell et al
showed that the co-existing of the 7472A>C variation
clearly influenced the phenotypic expression associated
with the 7472insC mutation by cybrids analysis[58].
Mechanism of Deafness-associated tRNA
Mutations
Mitochondrial tRNA mutations have a series of struc-
tural and functional effects, including destabilization of
tRNA tertiary structure, altered processing of RNA pre-
cursors, loss of nucleotide modification, deficient amino-
acylation, and reduced fidelity of anticodon-codon recog-
nition. Failures in tRNA metabolism caused by these mu-
tations lead to mitochondrial protein synthesis, and can
be worsened by the secondary tRNA mutations. These
mitochondrial translational defects result in a decline in
ATP production in the cochlear cells. At the meantime,
these defects in oxidative phosphorylation would in-
crease the production of reactive oxygen species (ROS),
thereby damaging these mitochondrial and cellular pro-
teins, lipids and nuclear acids. The hair cells and cochle-
ar neurons may be preferentially involved since they are
exquisitely sensitive to subtle imbalance in cellular re-
dox state or increased level of free radicals. Consequent-
ly, the mitochondrial permeability transition pore opens
and activates cell apoptosis. This would lead to the dys-
function or death of cochlear and vestibular cells, there-
by producing the phenotype of hearing loss.
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In summary, mutations in mitochondrial tRNAs repre-
sent an important molecular basis for maternally inherit-
ed hearing loss with or without additional symptoms.
The primary syndromic deafness-associated tRNA muta-
tions, such as tRNALeu(UUR) 3243A>G mutation involved
with MELAS, maternally inherited diabetes mellitus and
deafness (MIDD), are present at heteroplasmy with a typ-
ical threshold effect. Furthermore, the levels of hetero-
plasmic of these primary tRNA mutations are considered
to be a discriminator of the clinical phenotype and severi-
tyofthedisorder.However,thenon-syndromic-deafness-as-
sociated tRNA mutations, including tRNASer(UCN) 7445A>
G and 7511T>C mutations are often found in homoplas-
my or in high levels of heteroplasmy. These tRNA muta-
tions are the primary factors for the development of hear-
ing loss, while environmental factor(s), mtDNA haplo-
type(s) and nuclear modifier gene(s) may have a modify-
ing role in the penetrance and expressivity of deafness.
In particular, secondary tRNA mutations such as tRNAThr
15927G>A and tRNASer(UCN) 7444G>A act in synergy with
the primary tRNA mutations, modulating the phenotypic
manifestation.
Perspective
The genetic and biochemical evidence shows that the
mitochondrial tRNA mutations are one of the most im-
portant causes of deafness. However, the pathogenic
mechanism of these tRNA mutations need to be further
elucidated.Particularly,thetissue-specificityofthesepatho-
genic mtDNA mutations is likely due to tissue-specific
RNA processing, posttranscriptional modification or the
contribution of nuclear modifier genes, which may also
explain the wide range of phenotypic variability observed
among these hearing-loss families with the same prima-
ry mutation. Furthermore, the establishment of mice
model with these mitochondrial tRNA mutations is a crit-
ical approach for the further understanding of molecular
mechanisms in pathogenesis of tRNA mutations. There-
fore, these data will offer valuable information for the
development of early diagnosis, management, and treat-
ment approaches of maternally inherited hearing loss.
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